Follow
Dan Ishihara, MD, Ph.D.
Dan Ishihara, MD, Ph.D.
Transitional Year Resident, University of Hawaii
Verified email at hawaii.edu
Title
Cited by
Cited by
Year
Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment
D Ishihara, L Pop, T Takeshima, P Iyengar, R Hannan
Cancer Immunology, Immunotherapy 66, 281-298, 2017
642017
Wiskott-Aldrich syndrome protein regulates leukocyte-dependent breast cancer metastasis
D Ishihara, A Dovas, L Hernandez, M Pozzuto, J Wyckoff, JE Segall, ...
Cell reports 4 (3), 429-436, 2013
552013
Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck
WF Mourad, KS Hu, D Shasha, DAN ISHIHARA, W LIN, RA SHOURBAJI, ...
Anticancer research 34 (1), 243-248, 2014
532014
The chemotactic defect in wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions
D Ishihara, A Dovas, H Park, BM Isaac, D Cox
PloS one 7 (1), e30033, 2012
442012
Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis
H Park, D Ishihara, D Cox
Archives of biochemistry and biophysics 510 (2), 101-111, 2011
442011
N-WASP has the ability to compensate for the loss of WASP in macrophage podosome formation and chemotaxis
BM Isaac, D Ishihara, LM Nusblat, JC Gevrey, A Dovas, J Condeelis, ...
Experimental cell research 316 (20), 3406-3416, 2010
442010
Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy
WF Mourad, KS Hu, D Shasha, DAN ISHIHARA, W LIN, ME GAMEZ, ...
Anticancer research 33 (12), 5511-5516, 2013
252013
Outcome and immune correlates of a phase II trial of high-dose interleukin-2 and stereotactic ablative radiotherapy for metastatic renal cell carcinoma
R Hannan, O Mohamad, A Diaz de Leon, S Manna, LM Pop, Z Zhang, ...
Clinical Cancer Research 27 (24), 6716-6725, 2021
152021
Phase II trial of high-dose interleukin-2 (IL-2) and stereotactic radiation therapy (SABR) for metastatic clear cell renal cell carcinoma (ccRCC): Interim analysis.
R Hannan, D Ishihara, K Louder, C Ahn, V Margulis, YE Arriaga, ...
Journal of Clinical Oncology 34 (2_suppl), 532-532, 2016
122016
Tolerance and toxicity of primary radiation therapy in the management of seropositive HIV patients with squamous cell carcinoma of the head and neck
WF Mourad, KS Hu, D Ishihara, RA Shourbaji, W Lin, M Kumar, ...
The Laryngoscope 123 (5), 1178-1183, 2013
72013
The impact of computed tomography on early glottic cancer outcomes
WF Mourad, KS Hu, RA Shourbaji, D Ishihara, W Lin, M Kumar, DM Blakaj, ...
Onkologie 36 (3), 83-86, 2013
22013
Benefit of multimodality image acquisition in the treatment planning of stereotactic radiosurgery (SRS) of arteriovenous malformation (AVM)
D Ishihara, M Pinho, X Gu, S Stojadinovic, H Liu, R Timmerman
J Cancer Res Ther Oncol 8, 1-10, 2020
12020
Phase 2 Trial of High-Dose Interleukin-2 (IL-2) and Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Clear Cell Renal Cell Carcinoma (mRCC)—Interim Analysis of i …
D Ishihara, K Louder, M Akter, C Ahn, V Margulis, Y Arriaga, K Courtney, ...
International Journal of Radiation Oncology, Biology, Physics 96 (2), S96-S97, 2016
2016
The combination of radiation therapy and immunotherapy for genitourinary cancer treatment: rationale, current evidence, and prospects
D Ishihara, P Iyengar, J Meyer, R Timmerman, H Choy, R Hannan
Journal of Radiation Oncology 4, 355-363, 2015
2015
Mitteilungen onkologischer Gesellschaften· Reports of Oncological Societies
CT Germer, H Einsele, V Kunzmann, M de Wit, P Ortner, HP Lipp, ...
Oncology Research and Treatment 36 (3), 143-144, 2013
2013
Imprint
CT Germer, H Einsele, V Kunzmann, M de Wit, P Ortner, HP Lipp, ...
Oncology Research and Treatment 36 (3), 108-108, 2013
2013
PharmaNews/PharmaTicker
CT Germer, H Einsele, V Kunzmann, M de Wit, P Ortner, HP Lipp, ...
Oncology Research and Treatment 36 (3), 145-146, 2013
2013
Vol. 36, Issue 3, March 2013/Band 36, Heft 3, Marz 2013
CT Germer, H Einsele, V Kunzmann, M de Wit, P Ortner, HP Lipp, ...
Oncology Research and Treatment 36 (3), 78-79, 2013
2013
Contents of Forthcoming Issues· Themenvorschau
CT Germer, H Einsele, V Kunzmann, M de Wit, P Ortner, HP Lipp, ...
Oncology Research and Treatment 36 (3), 152-152, 2013
2013
Das nicht-kleinzellige Lungenkarzinom–Status Quo 2012
CT Germer, H Einsele, V Kunzmann, M de Wit, P Ortner, HP Lipp, ...
Oncology Research and Treatment 36 (3), I-I, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20